UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 339

Sortiert nach

Richness, not evenness, of invasive plant species promotes invasion success into native plant communities via selection effects

Oikos, 2022-06, Vol.2022 (6), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Elevated serum IL‐13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B‐cell lymphoma

Hematological oncology, 2023-04, Vol.41 (2), p.230-238

2023

Link zum Volltext

Verfügbarkeit prüfen

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (12), p.4826-4831

2008

Link zum Volltext

Verfügbarkeit prüfen

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up

American journal of hematology, 2014-07, Vol.89 (7), p.732-742

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (9), p.3342-3347

2009

Link zum Volltext

Verfügbarkeit prüfen

Deep learning based sequence detection with natural redundancy for memory sources

IET communications, 2023-06, Vol.17 (9), p.1140-1148

2023

Link zum Volltext

Verfügbarkeit prüfen

Expanding Nilotinib Access in Clinical Trials (ENACT): An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase

Cancer, 2012, Vol.118 (1), p.118-126

2012

Link zum Volltext

Verfügbarkeit prüfen

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2004-04, Vol.101 (15), p.5328-5335

2004

Link zum Volltext

Verfügbarkeit prüfen

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

Blood, 2010-10, Vol.116 (14), p.2448-2454

2010

Link zum Volltext

Verfügbarkeit prüfen

Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study

Chinese medical journal, 2021-06, Vol.134 (11), p.1299-1309

2021

Link zum Volltext

Verfügbarkeit prüfen

Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first‐line treatment of adult acute promyelocytic leukemia

European journal of haematology, 2018-04, Vol.100 (4), p.344-350

2018

Link zum Volltext

Verfügbarkeit prüfen

AML1-ETO and C-KIT Mutation/Overexpression in t(8;21) Leukemia: Implication in Stepwise Leukemogenesis and Response to Gleevec

Proceedings of the National Academy of Sciences - PNAS, 2005-01, Vol.102 (4), p.1104-1109

2005

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and therapeutic strategies for elderly patients with acute myeloid leukemia

Zhōnghuá xuèyèxué zázhì, 2013-01, Vol.34 (1), p.76-79

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics and Outcome of 66 Cases of Mantle Cell Lymphomas

Zhongguo shi yan xue ye xue za zhi, 2017-08, Vol.25 (4), p.1036

2017

Link zum Volltext

Verfügbarkeit prüfen

The progress of targeted therapy of hematological malignancies in recent 10 years

Chung-hua nei kʿo tsa chih, 2013-02, Vol.52 (2), p.121

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single‐arm, open‐label phase 2 study

Asia-Pacific journal of clinical oncology, 2018-06, Vol.14 (3), p.270-278

2018

Link zum Volltext

Verfügbarkeit prüfen

FLAG regimen in the treatment of refractory and relapsed acute myeloid leukemia

Zhōnghuá xuèyèxué zázhì, 2011-01, Vol.32 (1), p.1-2

Shen, Zhi-xiang

2011

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Blood, 2011-10, Vol.118 (17), p.4567-4576

2011

Link zum Volltext

Verfügbarkeit prüfen

NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis

Clinical cancer research, 2006-05, Vol.12 (10), p.3043-3049

2006

Link zum Volltext

Verfügbarkeit prüfen

Progress in the study of plasma-drug concentration of imatinib for treatment of chronic myeloid leukemia

Zhōnghuá xuèyèxué zázhì, 2012-01, Vol.33 (1), p.69-70

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer

World journal of gastroenterology : WJG, 2005-02, Vol.11 (8), p.1210

2005

Link zum Volltext

Verfügbarkeit prüfen

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide

EBioMedicine, 2015-06, Vol.2 (6), p.563-571

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Blood, 2015-04, Vol.125 (18), p.2771-2778

2015

Link zum Volltext

Verfügbarkeit prüfen

Chinese guidelines for the diagnosis and treatment of acute promyelocytic leukemia

Zhōnghuá xuèyèxué zázhì, 2011-12, Vol.32 (12), p.885-886

Shen, Zhi-xiang

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(299)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Richness, not evenness, of invasive plant species promotes invasion success into native plant communities via selection effects

Elevated serum IL‐13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B‐cell lymphoma

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

Deep learning based sequence detection with natural redundancy for memory sources

Expanding Nilotinib Access in Clinical Trials (ENACT): An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study

Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first‐line treatment of adult acute promyelocytic leukemia

AML1-ETO and C-KIT Mutation/Overexpression in t(8;21) Leukemia: Implication in Stepwise Leukemogenesis and Response to Gleevec

Characteristics and therapeutic strategies for elderly patients with acute myeloid leukemia

Clinical Characteristics and Outcome of 66 Cases of Mantle Cell Lymphomas

The progress of targeted therapy of hematological malignancies in recent 10 years

Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single‐arm, open‐label phase 2 study

FLAG regimen in the treatment of refractory and relapsed acute myeloid leukemia

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis

Progress in the study of plasma-drug concentration of imatinib for treatment of chronic myeloid leukemia

Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial

Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Chinese guidelines for the diagnosis and treatment of acute promyelocytic leukemia

Suchergebnisse filtern